mRNA |
BRD1835 |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.3 |
mRNA |
Bortezomib |
GDSC1000 |
pan-cancer |
AAC |
0.05 |
0.3 |
mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.3 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.3 |
mRNA |
bafilomycin A1 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.3 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.3 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
JNK Inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
Vorinostat |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.3 |